09-08 Pulsenmore Completes CE European Registration Of Home Ultrasound System For Follicular Monitoring CI
08-31 Pulsenmore Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-19 Pulsenmore Ltd. announces the expansion of its activities in Israel CI
08-18 Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program AQ
08-17 Pulsenmore Ltd Receives Israel Innovation Authority Grant Of USD 1.27 Million For Smartscan AI Program CI
07-13 Pulsenmore Selected For Israel Innovation Authority And Ministry Of Health Program To Lead $1 Million AI Development Project CI
07-02 Pulsenmore Files Resale Registration for 3.1 Million Shares MT
06-26 Pulsenmore Ltd. announced that it has received $7.499844 million in funding CI
06-25 Pulsenmore to Raise $7.5 Million in Equity Private Placement MT
06-24 Pulsenmore Ltd. announced that it expects to receive $7.499844 million in funding CI
06-24 Top Midday Gainers MT
06-24 Pulsenmore Enters Partnership with Ouma Health for its Home Ultrasound Platform; Shares Rise Pre-Bell MT
06-24 Pulsenmore Ltd. And Ouma Health Enter Strategic Partnership To Expand Access To Remote Prenatal Care Across The United States CI
03-30 Pulsenmore : Corporate Presentation (Pulsenmore Investor Deck 03302026 ) PU
03-30 Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-18 Pulsenmore : Announces Full Year 2025 Earnings Conference Call PU
02-09 Pulsenmore Ltd. Enters Commercial Engagement With TLC Perinatal For Home Ultrasound Services In U.S CI
02-02 Pulsenmore Ltd. Announces First Commercial Engagement with a Leading U.S. Based Medical Center CI
01-26 Pulsenmore Ltd. and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation CI
01-21 Pulsenmore Ltd.(NasdaqCM:PLSM) added to NASDAQ Composite Index CI
01-20 Pulsenmore Ltd. will Change its Ticker to PLSM from PULS CI
11-03 Pulsenmore Ltd. Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S CI
11-03 Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S. PR
25-08-30 Pulsenmore Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-03-30 Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
No results match your criteria
  1. Stock Market
  2. Stocks
  3. PLSM Stock
  4. News Pulsenmore Ltd.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!